electroCore, Inc.

NASDAQ:ECOR

Medical - Devices

Healthcare
$7.71 -5.70%

-$0.50 today

Market cap
$71.13M
Beta
0.87
P/E (TTM)
-4.8
EPS (TTM)
-$1.72
52W Low $4.16High $10.50

Volume 0.06M

Average 0.11M

ECOR Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

electroCore, Inc.NASDAQ: ECOR

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 8.95M shares rose 8.0% year over year, behind the +9.1% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 11.9% from the prior quarter. Over 3 fiscal years it compounded at +21.5% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +8.0% toward the trailing-twelve-month pace of +9.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
8.95M+11.9% QoQ
Last fiscal yearDec 2025
8.48M+13.4% YoY
LTMMar 2026
8.43M+9.1% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.0%——
1 year+13.4%——
3-year CAGR+21.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
8.48M USD
Year-over-year change
+13.4%
4-year CAGR
+21.1%

Weighted Avg Shares (Diluted) vs competitors

How ECOR compares with its peers on the latest reported figures

  • ECOR's LTM Mar 2026 weighted avg shares (diluted) of 8.43M shares is the lowest of the 6 companies compared; the peer median is 31.93M shares.
  • Its year-over-year change of +9.1% is the 5th highest of 6, against a peer median of +42.8%.
  • Over three fiscal years its annual growth of +21.5% compares with a peer median of +81.1%.
ECOR Competitors Peer median
Weighted Avg Shares (Diluted) for ECOR and competitors
Company Period LTM YoY 3-year CAGR
MYOMyomo, Inc.LTM Mar 202641.97M +7.8%+81.1%
RNXTRenovoRx, Inc.LTM Mar 202636.65M +42.8%+25.0%
MAIAMAIA Biotechnology, Inc.LTM Mar 202631.93M +27.8%+51.3%
PYPDPolyPid Ltd.LTM Mar 202618.85M +145.8%+132.9%
HYPDHyperion DeFi, Inc.LTM Jun 20268.75M +921.9%+128.2%
ECORelectroCore, Inc.LTM Mar 20268.43M +9.1%+21.5%
Peer median (excluding ECOR) 31.93M+42.8%+81.1%

Competitors are the stored peer set for ECOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.45M8.59M16.03M25.18M32.03M
Cost of Revenue1.39M1.62M2.8M3.79M4.24M
Gross Profit4.07M6.98M13.23M21.4M27.79M
Gross Margin74.6%81.2%82.5%85.0%86.8%
Research & Development2.54M5.52M5.32M2.36M2.74M
Selling, General & Admin21.57M24.33M26.71M31.2M38.21M
Operating Expenses24.11M29.85M32.03M33.56M40.94M
Depreciation & Amortization382K596K1.26M1.26M1.68M
EBITDA(17.69M)(22M)(17.76M)(10.72M)(11.7M)
EBITDA Margin-324.5%-256.0%-110.8%-42.6%-36.5%
Operating Income(20.04M)(22.87M)(18.81M)(12.16M)(13.15M)
Operating Margin-367.7%-266.2%-117.3%-48.3%-41.1%
Interest Income11K287K433K572K298K
Interest Expense0000590K
Other Income / Expenses1.97M281K(215K)183K(810K)
Income Before Tax(18.07M)(22.59M)(19.02M)(11.98M)(13.96M)
Pre-Tax Margin-331.5%-263.0%-118.7%-47.6%-43.6%
Income Tax Expense(851K)(431K)(186K)(93K)3K
Net Income(17.22M)(22.16M)(18.83M)(11.89M)(13.97M)
Net Margin-315.9%-257.9%-117.5%-47.2%-43.6%
EPS (Basic)(4.36)(4.69)(3.42)(1.59)(1.65)
EPS (Diluted)(4.36)(4.69)(3.42)(1.59)(1.65)
Weighted Avg Shares3.95M4.73M5.52M7.48M8.48M
Weighted Avg Shares (Diluted)3.95M4.73M5.52M7.48M8.48M

electroCore, Inc.

NASDAQ:ECOR

Intrinsic Alpha fair value

Locked

Current Price

$7.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.